Differential effects of ADORA2A gene variations in pre-attentive visual sensory memory subprocesses

European Neuropsychopharmacology

Volumn 22, Issue 8, 2012, Pages 555-561

  Beste, Christian ^a   Stock, Ann Kathrin ^a   Ness, Vanessa ^a   Epplen, Jörg T ^a   Arning, Larissa ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Adenosine; ; ADORA2A; Attention; ; Partial report; ; Sensory memory;

Indexed keywords

ADENOSINE A2A RECEPTOR; GLUTAMIC ACID;

ADULT; ARTICLE; ATTENTION; COGNITION; DNA POLYMORPHISM; FEMALE; GENE; GENE EXPRESSION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; NERVE CELL; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; SENSORY MEMORY; SIGNAL TRANSDUCTION; TASK PERFORMANCE; VISUAL STIMULATION; WORKING MEMORY;

ADULT; ALGORITHMS; ATTENTION; FEMALE; GENETIC ASSOCIATION STUDIES; GERMANY; HUMANS; MALE; MEMORY, SHORT-TERM; NERVE TISSUE PROTEINS; PHOTIC STIMULATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTION TIME; RECEPTOR, ADENOSINE A2A; SIGNAL DETECTION, PSYCHOLOGICAL; VISUAL PERCEPTION; YOUNG ADULT;

EID: 84864535138     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.12.004     Document Type: Article

References (43)

1. Alsene K., Deckert J., Sand P., de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003, 28:1694-1702.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Beal M.F., Ferrante R.J. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat. Rev. Neurosci. 2004, 5:373-384.
4. Beste C., Saft C., Güntürkün O., Falkenstein M. Increased cognitive functioning in symptomatic Huntington's disease as revealed by behavioral and event-related potential indices of auditory sensory memory and attention. J. Neurosci. 2008, 28:11695-11702.
5. Beste C., Schneider C., Epplen J.T., Arning L. The functional BDNF Val66Met polymorphism affects functions of pre-attentive visual sensory memory processes. Neuropharmacology 2010, 60:467-471.
6. Blum D., Hourez R., Galas M.C., Popoli P., Schiffmann S.N. Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics. Lancet Neurol. 2003, 2:366-374.
7. Childs E., Hohoff C., Deckert J., Xu K., Badner J., de Wit H. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2008, 33:2791-2800.
8. Coltheart M. Iconic memory and visible persistence. Percept. Psychophys. 2011, 27:183-288.
9. Deckert J., Nöthen M.M., Franke P., Delmo C., Fritze J., Knapp M., Maier W., Beckmann H., Propping P. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol. Psychiatry 1998, 3:81-85.
10. Dheanens C.M., Burnouf S., Simonin C., Van Brussel E., Duhamel A., Defebvre L., Duru C., Vuillaume I., Cazeneuve C., Charles P., Maison P., Debruxelles S., Verny C., Gervais H., Azulay J.P., Tranchant C., Bachoud-Levi A.C., Dürr A., Buee L., Krystkowiak P., Sablonniere B., Blum D. A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol. Dis. 2009, 35:474-476.
11. Di Lollo V. Temporal characteristics of sensory memory. Nature 1977, 267:241-243.
12. Domenici M.R., Pepponi R., Martire A., Tebano M.T., Potenza R.L., Popoli P. Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGLUR5)-mediated effects in the striatum. J. Neurochem. 2004, 90:1276-1279.
13. Ferre S., Quiroz C., Orru M., Guitart X., Navarro G., Cortes A., Casado V., Canela E.I., Lluis C., Franco R. Adenosine A(2) receptors and A(2A) receptor heteromers as key players in striatal function. Front. Neuroanat. 2011, 36. [Epub ahead of print].
14. Freitag C.M., Agelopoulos K., Huy E., Rothermund M., Krakowitzky P., Meyer J., Deckert J., von Gontard A., Hohoff C. Adenosine A(2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder. Eur. Child Adolesc. Psychiatry 2010, 19:67-74.
15. Fuxe K., Ferre S., Genedani S., Franco R., Agnati L.F. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol. Behav. 2007, 92:210-217.
16. Gegenfurtner K.R., Sperling G. Information transfer in iconic memory experiments. J. Exp. Psychol. Hum. Percept. Perform. 1993, 19:845-866.
17. Gołembiowska K., Zylewska A. Adenosine receptors - the role in modulation of dopamine and glutamate release in the rat striatum. Pol. J. Pharmacol. 1997, 49:317-322.
18. Goñi J.R., de la Cruz X., Orozco M. Triplex-forming oligonucleotide target sequences in the human genome. Nucleic Acids Res. 2004, 32:354-360.
19. Hamilton S.P., Slager S.L., De Leon A.B., Heiman G.A., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., Knowles J.A. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 2004, 29:558-565.
20. Higley M.J., Sabatini B.L. Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors. Nat. Neurosci. 2010, 13:958-966.
21. Hohoff C., McDonald J.M., Baune B.T., Cook E.H., Deckert J., de Wit H. Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 139B:42-44.
22. Hohoff C., Domschke K., Schwarte K., Spellmeyer G., Vögele C., Hetzel G., Deckert J., Gerlach A.L. Sympathetic activity relates to adenosine A(2A) receptor gene variation in blood-injury phobia. J. Neural Transm. 2009, 116:659-662.
23. Hohoff C., Mullings E.L., Heatherley S.V., Freitag C.M., Domschke K., Krakowitzky P., Rothermund M., Keck M.E., Unschuld P.G., Jacob C., Fritze J., Nadelow B., Maie W., Holsboer F., Rogers P.J., Deckert J. Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J. Psychiatr. Res. 2010, 44:930-937.
24. Jagannathan K., Calhoun V.D., Gelernter J., Stevens M.C., Liu J., Bolognani F., Windemuth A., Ruano G., Assaf M., Pearlson G.D. Genetic associations of brain structural networks in schizophrenia: a preliminary study. Biol. Psychiatry 2010, 68:657-666.
25. Javitt D.C., Steinschneider M., Schrieder C.E., Arezo J.C. Role of cortical N-methyl-d-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1962-1967.
26. Knudsen E.I. Fundamental components of attention. Annu. Rev. Neurosci. 2007, 30:57-78.
27. Kohlmetz C., Altenmüller E., Schuppert M., Wieringa B.M., Münte T.F. Deficit in automatic sound-change detection may underlie some music perception deficits after acute hemispheric stroke. Neuropsychologia 2001, 39:1121-1124.
28. Kujala T., Tervaniemi M., Schröger E. The mismatch negativity in cognitive and clinical neuroscience, theoretical and methodological considerations. Biol. Psychol. 2007, 74:1-19.
29. Lu Z.L., Neuse J., Madigan S., Dosher B.A. Fast decay of iconic memory in observers with mild cognitive impairments. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1797-1802.
30. Näätänen R., Paavilainen P., Rinne T., Alho K. The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clin. Neurophysiol. 2007, 118:2544-2590.
31. Okada M., Mizuno K., Kaneko S. Adenosine A1 and A2 receptors modulate extracellulardopamine levels in rat striatum. Neurosci. Lett. 1996, 212:53-56.
32. Okamoto S., Pouladi M.A., Talantova M., Yao D., Xia P., Ehrnhoefer D.E., Zaidi R., Clemente A., Kaul M., Graham R.K., Zhang D., Vincent Chen H.S., Tong G., Hayden M.R., Lipton S.A. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat. Med. 2009, 15:1407-1413.
33. Pekkonen E. Mismatch negativity in aging and in Alzheimer's and Parkinson's diseases. Audiol. Neurootol. 2000, 5:216-224.
34. Popoli P., Betto P., Reggio R., Ricciarello G. Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur. J. Pharmacol. 1995, 287:215-217.
35. Popoli P., Blum D., Domenici M.R., Burnouf S., Chern Y. A critical evaluation of adenosine A2A receptors as potentially "druggable" targets in Huntington's disease. Curr. Pharm. Des. 2008, 14:1500-1511.
36. Redgrave P., Gurney K. The short-latency dopamine signal: a role in discovering novel actions?. Nat. Rev. Neurosci. 2006, 7:967-975.
37. Rogers P.J., Hohoff C., Heatherley S.V., Mullings E.L., Maxfield P.J., Evershed R.P., Deckert J., Nutt D.J. Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology 2010, 35:1973-1983.
38. Saneyoshi A., Niimi R., Suetsugu T., Kaminaga T., Yokosawa K. Iconic memory and parietofrontal network: fMRI study using temporal integration. Neuroreport 2011, 22:515-519.
39. Schiffmann S.N., Fisone G., Moresco R., Cunha R.A., Ferre S. Adenosine A2A receptors and basal ganglia physiology. Prog. Neurobiol. 2007, 83:277-292.
40. Taherzadeh-Fard E., Saft C., Wieczorek S., Epplen J.T., Arning L. Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1. Neurogenetics 2010, 11:435-439.
41. Umbricht D., Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr. Res. 2005, 76:1-23.
42. Umbricht D., Koller R., Vollenweider F.X., Schmid L. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol. Psychiatry 2002, 51:400-406.
43. Yu L., Frith M.C., Suzuki Y., Peterfreund R.A., Gearan T., Sugano S., Schwarzschild M.A., Weng Z., Fink J.S., Chen J.F. Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses. Brain Res. 2004, 1000:156-173.